The North America OTC hyaluronic acid market size is expected to reach USD 10.29 billion by 2030, registering a CAGR of 7.9% during the forecast period, according to a new report by Grand View Research, Inc. The increasing number of obese people owing to the lack of physical activity and higher consumption of fast food & alcohol, especially by the younger population are some of the factors accounting for growth.
Orthopedic applications of hyaluronic acid (HA) are expected to emerge as the most lucrative segment of this market. This can be attributed to the growing target audience above 60 years, suffering from various joint disorders such as rheumatoid arthritis and osteoarthritis coupled with the introduction of new products catering to this population subset. In addition, an increase in the number of arthritis-related hospitalization cases and growing awareness amongst the healthcare professionals regarding excellent physiochemical properties of hyaluronic acid is expected to drive the demand. The growing population of women between 20 and 65 years of age and increasing awareness regarding the benefits of HA is some of the crucial factors driving the surging demand for hyaluronic acid in dermatological procedures.
Hyaluronic acid (HA) stimulates the synthesis of a protein that plays a crucial role in supporting skin structure and collagen, which declines with age leading to wrinkling formation. The growing demand for HA as a topical skin cream or serum coupled with the increasing presence of market participants in this sector is indicative of future growth. The rising awareness regarding the benefits of HA in skincare products for penetrating the dermis more effectively as compared to collagen is also anticipated to propel the market trend. According to various reports, approximately 27% of the total U.S. women population belong to the age group of 45 to 65 years, which is one of the crucial factors responsible for the surging demand for anti-wrinkle creams.
Some of the key players are Shiseido Co., Ltd.; Lindberg Nutrition & GeniusCentral Systems; Nature’s Way Products, LLC; NOW Foods; NeoCell Corporation; Source Naturals, Inc.; Doctors Best; derma e; and Earth Science Naturals.
Request a free sample copy or view report summary: North America OTC Hyaluronic Acid Market Report
By product, Dermatology segment accounted for the largest market revenue share in 2023. The rapid growth of this segment is being fueled by a surge in demand for HA-based fillers for various procedures, as well as a rise in cases of skin concerns such as wrinkles, acne, and scarring.
Orthopedics is expected to register the fastest growth during the forecast period, driven by the rise of musculoskeletal disorders, sports injuries, and fractures.
By sales channel, retail accounted for the largest market revenue share of 83.7% in 2023. Main factors that is anticipated to drive the market is the easy access to cosmetics and joint supplements in drug stores, departmental stores, and supermarkets.
Grand View Research has segmented the North America OTC hyaluronic acid market report based on product, sales channel, and country:
North America OTC Hyaluronic Acid Product Outlook (Revenue, USD Million, 2018 - 2030)
Dermatology
Moisturizers
Anti-wrinkle Crème
Orthopedics
North America OTC Hyaluronic Acid Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)
Retail
Online
North America OTC Hyaluronic Acid Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
California
Texas
New York
Florida
Illinois
Other States
Canada
Mexico
List of Key Players in the North America OTC Hyaluronic Acid Market
Shiseido Company
Lindberg Nutrition Products
Nature’s Way
Now Foods
NeoCell Corporation
Source Naturals, Inc.
Doctor’s Best
Derma E
Earth Science
"The quality of research they have done for us has been excellent..."